Medtronic Receives FDA Marketing Clearance For Complete SE Biliary Stent System

[Guest guest]

Medtronic

Receives FDA Marketing Clearance For Complete SE

Biliary Stent System

Article Date: 19 Nov 2007 - 4:00

PST

Medtronic, Inc. announced that it has received 510(k) marketing clearance from

the U.S. Food and Drug Administration for the Complete SE (self-expanding)

Biliary Stent System, which is indicated for use in the palliative treatment of

malignant neoplasms in the biliary tree - cancerous

tumors in the bile duct that can compromise digestion by restricting the flow

of digestive fluids.

U.S. commercial

sales of the new biliary stent will begin immediately in a wide size range,

with diameters of 4 - 10 mm and lengths of 20 - 150 mm.

Bench testing has shown the Complete SE Biliary Stent System to be

extremely accurate in terms of stent placement. Accurate

stent placement can decrease the likelihood that additional stents are

necessary to cover the entire narrowing of the bile duct.

Barb in Texas - Together in the

Fight, Whatever it Takes!

Son Ken (33) UC 91 - PSC 99 - Tx 6/21 & 6/30/07 @ Baylor in Dallas